Potential Protection Against Type 2 Diabetes in Obesity Through Lower CD36 Expression and Improved Exocytosis in β-Cells.
Journal
Diabetes
ISSN: 1939-327X
Titre abrégé: Diabetes
Pays: United States
ID NLM: 0372763
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
19
09
2019
accepted:
09
03
2020
pubmed:
22
3
2020
medline:
23
10
2020
entrez:
22
3
2020
Statut:
ppublish
Résumé
Obesity is a risk factor for type 2 diabetes (T2D); however, not all obese individuals develop the disease. In this study, we aimed to investigate the cause of differential insulin secretion capacity of pancreatic islets from donors with T2D and non-T2D (ND), especially obese donors (BMI ≥30 kg/m
Identifiants
pubmed: 32198214
pii: db19-0944
doi: 10.2337/db19-0944
pmc: PMC7243297
doi:
Substances chimiques
Antibodies
0
CD36 Antigens
0
Insulin
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1193-1205Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020 by the American Diabetes Association.
Références
PLoS One. 2012;7(10):e47381
pubmed: 23077605
Diabetes. 1999 Sep;48(9):1686-90
pubmed: 10480595
Proc Natl Acad Sci U S A. 2014 Sep 23;111(38):13924-9
pubmed: 25201977
Annu Rev Nutr. 2008;28:233-51
pubmed: 18481923
Science. 2016 Oct 7;354(6308):69-73
pubmed: 27846494
PLoS One. 2015 Mar 24;10(3):e0120879
pubmed: 25803449
J Biol Chem. 2003 Mar 21;278(12):10297-303
pubmed: 12525490
Cell Metab. 2009 Dec;10(6):455-65
pubmed: 19945403
Cell Metab. 2007 Oct;6(4):267-79
pubmed: 17908556
Endocrinology. 2016 Feb;157(2):570-85
pubmed: 26650570
Nat Rev Endocrinol. 2013 Oct;9(10):615-23
pubmed: 23959366
Nature. 2017 Jan 5;541(7635):41-45
pubmed: 27974793
J Intern Med. 2013 Jul;274(1):25-40
pubmed: 23551521
Cell Metab. 2007 Oct;6(4):320-8
pubmed: 17908560
Mol Cell Endocrinol. 2012 Nov 25;364(1-2):36-45
pubmed: 22939844
J Biol Chem. 2011 Apr 15;286(15):13647-56
pubmed: 21335550
Diabetes. 2005 Feb;54(2):472-81
pubmed: 15677505
Cell Metab. 2018 Feb 6;27(2):470-478.e4
pubmed: 29414688
J Diabetes Investig. 2011 Apr 7;2(2):82-91
pubmed: 24843466
Crit Rev Food Sci Nutr. 2017 May 24;57(8):1673-1680
pubmed: 26147190
Mol Metab. 2018 Feb;8:144-157
pubmed: 29307512
Diabetes Obes Metab. 2012 Oct;14 Suppl 3:152-60
pubmed: 22928576
Diabetologia. 2007 Apr;50(4):752-63
pubmed: 17268797
Diabetes. 1995 Aug;44(8):863-70
pubmed: 7621989
Nat Rev Mol Cell Biol. 2018 Jan;19(1):31-44
pubmed: 28974775
J Mol Endocrinol. 2006 Jun;36(3):503-15
pubmed: 16720719
Pflugers Arch. 2002 May;444(1-2):43-51
pubmed: 11976915
Endocr Rev. 2008 May;29(3):351-66
pubmed: 18048763
Clin Lipidol. 2013 Dec;8(6):659-667
pubmed: 24533033
Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):8919-24
pubmed: 22566644
Diabetologia. 2012 Oct;55(10):2565-2582
pubmed: 22869320
J Clin Invest. 2011 Sep;121(9):3589-97
pubmed: 21865645
Cell. 1999 Feb 5;96(3):329-39
pubmed: 10025399
Diabetologia. 2003 Aug;46(8):1029-45
pubmed: 12879249
Biochim Biophys Acta. 2010 Feb;1801(2):191-7
pubmed: 19931418
Cell Metab. 2010 Dec 1;12(6):619-32
pubmed: 21109194
Biochemistry. 1997 Oct 21;36(42):12939-47
pubmed: 9335553
Front Endocrinol (Lausanne). 2018 Jul 16;9:384
pubmed: 30061862
J Biol Chem. 2002 Dec 13;277(50):48115-21
pubmed: 12351658
J Biol Chem. 1999 Sep 17;274(38):26761-6
pubmed: 10480880
Biochim Biophys Acta. 2015 Nov;1852(11):2414-22
pubmed: 26297980
Physiol Behav. 2011 Nov 30;105(1):36-42
pubmed: 21354192
Cell Metab. 2006 Aug;4(2):143-54
pubmed: 16890542
Diabetes. 2012 Jul;61(7):1726-33
pubmed: 22492527
Diabetes. 2008 Jul;57(7):1774-83
pubmed: 18586909
Cell Transplant. 2018 Jul;27(7):1031-1038
pubmed: 29945463
Physiol Rep. 2017 Nov;5(21):
pubmed: 29122960
Diabetes. 2009 Dec;58(12):2718-25
pubmed: 19940235
Diabetes. 2010 Jan;59(1):119-27
pubmed: 19826167
Diabetes. 2006 Feb;55(2):435-40
pubmed: 16443778
Endocrinology. 1999 Aug;140(8):3422-8
pubmed: 10433196
Diabetes. 2013 Jul;62(7):2157-63
pubmed: 23801714